-
Mashup Score: 3Breast Cancer FAQs - Friends of Max - 2 month(s) ago
On International Women’s Day Friends of Max is proud to launch a booklet on Frequently Asked Questions on Breast Cancer
Source: friendsofmax.infoCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 4Announcing 2024 teams - 2 month(s) ago
$25m each over five years to tackle some of cancer’s toughest challenges Meet the five new global teams selected to receive up to $25m each over five years to come together and think differently to drive progress against cancer. This $125m investment marks Cancer Grand Challenges’ largest funding round to date. Meet the teams below. Meet KOODAC, whose challenge is to develop therapeutics to target oncogenic drivers of solid tumours in children + Harnessing the technologies of targeted protein degradation
Source: cancergrandchallenges.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 3
Advanced breast cancer (ABC) is an incurable disease. The number of people living with ABC has increased globally. Disparities in ABC care exist at bo…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 7
PURPOSE Human epidermal growth factor receptor 2 (HER2) overexpression is seen in 4%-16% of biliary tract cancers (BTCs). We aimed to evaluate the clinical activity of gemcitabine-cisplatin (GC) plus anti-HER2 antibody trastuzumab as initial treatment in HER2-positive BTCs. METHODS This study was an investigator-initiated, open-label, single-arm, multi-institutional, phase II trial in adult patients with HER2-positive (defined as immunohistochemistry [IHC] 3+ or IHC 2+ and fluorescent in situ hybridization–positive), treatment-naïve BTCs. The primary end point of the study was 6-month progression-free survival (PFS). Next-generation sequencing was performed on tissue samples to evaluate mutational status. RESULTS From March 2020 to August 2022, of the 876 screened patients, 118 (13.4%) were found to have HER2-positive status, of whom 90 were enrolled in the study. Most patients had GBC (n = 96; 96%) with two or more sites of metastatic disease (n = 70; 78%). With a median follow-up of
Source: ascopubs.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 3Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers - 10 month(s) ago
Journal of Gastrointestinal Cancer – Total neoadjuvant therapy (TNT) with pre-operative chemotherapy and chemoradiotherapy results in improved survival and is becoming the new standard of care in…
Source: link.springer.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 1Common Sense Oncology – Outcomes That Matter - 10 month(s) ago
Oncology needs a recalibrated approach that is more patient centred and prioritizes equitable cancer care. Our approach prioritizes patients’ needs, advocates for treatments that improve survival and quality-of-life, promotes informed decision making, and ensures these treatments are accessible to all…
Source: commonsenseoncology.orgCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 3Common Sense Oncology – Outcomes That Matter - 10 month(s) ago
Oncology needs a recalibrated approach that is more patient centred and prioritizes equitable cancer care. Our approach prioritizes patients’ needs, advocates for treatments that improve survival and quality-of-life, promotes informed decision making, and ensures these treatments are accessible to all…
Source: commonsenseoncology.orgCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 1Common Sense Oncology – Outcomes That Matter - 10 month(s) ago
Oncology needs a recalibrated approach that is more patient centred and prioritizes equitable cancer care. Our approach prioritizes patients’ needs, advocates for treatments that improve survival and quality-of-life, promotes informed decision making, and ensures these treatments are accessible to all…
Source: commonsenseoncology.orgCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 1Common Sense Oncology – Outcomes That Matter - 10 month(s) ago
Oncology needs a recalibrated approach that is more patient centred and prioritizes equitable cancer care. Our approach prioritizes patients’ needs, advocates for treatments that improve survival and quality-of-life, promotes informed decision making, and ensures these treatments are accessible to all…
Source: commonsenseoncology.orgCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0Common Sense Oncology – Outcomes That Matter - 10 month(s) ago
Oncology needs a recalibrated approach that is more patient centred and prioritizes equitable cancer care. Our approach prioritizes patients’ needs, advocates for treatments that improve survival and quality-of-life, promotes informed decision making, and ensures these treatments are accessible to all…
Source: commonsenseoncology.orgCategories: Latest Headlines, Oncologists2Tweet
RT @Friends_Of_Max: https://t.co/ejuh2ghsRw On @womensday @Friends_Of_Max is proud to launch a booklet on Frequently Asked Questions on B…